Dr. Woods is the Co-Director of the Hubert-Yeargan Center for Global Health. He is a professor in the Departments of Medicine and Pathology at Duke University; an adjunct professor in Epidemiology at the University of North Carolina at Chapel Hill School of Public Health; an adjunct professor in the Emerging Infections Program at the Duke-National University of Singapore Graduate Medical School. Clinically, he serves as Chief of Infectious Diseases and clinical microbiology, and hospital epidemiologist for the Durham VA Medical Center. Dr. Woods is board-certified in internal medicine, infectious diseases, and medical microbiology.
Dr. Woods attended Yale University and pursued his medical education and training at Duke University and public health training at UNC-Chapel Hill. He is a graduate of the Epidemic Intelligence Service (EIS) of the Centers for Disease Control and Prevention (CDC), where he served in the Meningitis and Special Pathogens Branch of the National Center for Infectious Diseases. He formulated his interest in global health at Tenwek Hospital in Bomet, Kenya during his internal medicine residency and while at CDC, Dr. Woods performed programmatic work and outbreak investigations throughout the U.S. and the developing world. He currently serves as the Director of Graduate Studies and the MSc for Global Health in the Duke Global Health Institute.
Dr. Woods has published over 130 peer-reviewed articles and has a particular interest in development of medical microbiology capacity in the developing world and the epidemiology of emerging and re-emerging infectious diseases. His research focuses on the development of novel diagnostic approaches to infectious disease and the potential for interspecies transmission of pathogens. His genomic approach to harnessing the host response for diagnosis of infectious diseases has been called a paradigm shift in the field. Dr. Woods is a partner in the Southeastern Center for Emerging Biological Threats, core PI of the Southeastern Research Center for Excellence on Emerging Infections and Biodefense, and a leader in the NIH-funded Vaccine and Therapeutics Evaluation Unit at Duke.
One Health: From Philosophy to Practice
Interdisciplinary course introducing construct of One Health as increasingly important to a holistic understanding of prevention of disease and maintenance of health. Includes discussion of bidirectional impact of animal health on human health, impact of earthâs changing ecology on health. Learning objectives include 1) to describe how different disciplines contribute to the practice of One Health, 2) to creatively design interdisciplinary interventions to improve Global Health using a One Health model. Course will include weekly 2-hour multi-campus seminar off-site at NC Biotechnology Center with on-campus discussion section using case studies to supplement the seminar.
Was: GLHLTH 371
|GRAD Only||SPRING 2015||
Ungraded Research in Global Health
Individual research in a field of special interest, the central goal of which is a substantive paper containing significant analysis and interpretation of a previously approved topic. Consent required. Individual research in a field of special interest, the central goal of which is a substantive paper containing significant analysis and interpretation of a previously approved topic. Consent required
Was: GLHLTH 381
|GRAD Only||SPRING 2015||MSC: Thesis|
Global Health Challenges
Course introduces major global health problems and social, behavioral, economic, biomedical and environmental determinants of health in resource limited settings. Topics include communicable diseases i.e. HIV, malaria, tuberculosis and common childhood diseases; chronic diseases such as cancer, diabetes, cardiovascular disease and mental health; and determinants of health associated with these diseases, such as poverty, gender imbalance, culture, poor environmental sanitation, malnutrition, tobacco use, and climate change. Other topics may include health promotion, reproductive health, maternal and child health, and disaster preparedness.
Was: GLHLTH 310
|GRAD Only||FALL 2014||
Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH. Impact of Strain Types on Detection of Toxigenic Clostridium difficile: Comparison of Molecular Diagnostic and Enzyme Immunoassay Approaches. J Clin Microbiol. 2010 Aug 11.
Pien BC, Sundaram P, Raoof N, Costa SF, Mirrett S, Woods CW, Reller LB, Weinstein MP. The The clinical and prognostic importance of positive blood cultures in adults. Am J Med. 2010 Sep;123(9):819-28.
She-Bender R, Caram LB, Polage C, Woods CW, Petti C. Performance of diagnostic tests to detect respiratory viruses in older adults. Diagn Microbiol Infect Dis. 2010 Jul;67(3):246-50.
Oliveira AM, Maggi RG, Woods CW, Breitschwerdt EB. Suspected Needle Stick Transmission of Bartonella vinsonii subspecies berkhoffii to a Veterinarian.J Vet Intern Med. 2010 Jul 28.
Naggie S, Frederick J, Pien BC, Miller BA, Provenzale DT, Goldberg KC, Woods CW. Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. Infection. 2010 May 8. (Epub ahead of print)
Glickman SW, Tsalik EL, Cairns CB, Otero RM, Woods CW, Langley RJ, van Velkinburgh JC, Fowler VG, Glickman LT, Kingsmore SF, Rivers EP. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Academic Emergency Medicine 2010 Apr;17(4):383-90.
Breitschwerdt EB, Maggi RB, Lantos PL, Woods CW, Hegarty HC, Bradley JM. Bartonella vinsonii subsp. berkhoffii and Bartonella henselae bacteremia in a father and daughter with neurological disease. Parasites & Vectors 2010, 3:29
Peterson LR, Liesenfeld O, Woods CW, Allen SD, Pombo D, Patel PA, Mehta MS, Nicholson B, Fuller D, Onderdonk A. Multicenter Evaluation of the LightCycler(R) MRSA Advanced Test as a Rapid Method for Detection of Methicillin-resistant Staphylococcus aureus (MRSA) in Nasal Surveillance Swabs.. J Clin Microbiol. 2010 May;48(5):1661-6. Epub 2010 Mar 24.
Shao HJ, Crump JA, Ramadhani HO, Uiso LO, Ole-Nguyaine S, Moon AM, Kiwera RA, Woods CW, Shao JF, Bartlett JA, Thielman NM. Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania. AIDS Res Hum Retroviruses. 2009 Dec;25(12):1277-85.
Tsalik EL, Hendershot EF, Sangvai DG, Cunningham HM, Cunningham CK, Lopez-Marti MG, Purdy WK, Woods CW, Caram LB. Clinical presentation and response to treatment of novel influenza A H1N1 in a university-based summer camp population. J Clin Virol. 2010 Mar;47(3):286-8. Epub 2010 Jan 12.
Kutty PK, Woods CW, Sena AC, Benoit SR, Naggie S, Frederick J, Evans S, Engel J, McDonald LC. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010 Feb;16(2):197-204.